Ipsc generation and beta cell differentiation
Ended Purchase Order Awarded Last action
- Contract number
- 75N92025P00392
- Awardee
-
New York Stem Cell Foundation Inc. UEI ZCKCL8KFL3B9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- iPSC generation and beta cell differentiation Solicitation · 75N92025Q00135 · Posted Aug 27, 2025
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$361,950 | |
| Original award | $361,950 |
About this award
This is a $361,950 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to the New York Stem Cell Foundation Inc., a non-profit organization and foundation. The contract is for the generation of induced pluripotent stem cells (iPSCs) and the differentiation of beta cells. The work will be performed in Bethesda, Maryland, and the contract has an ultimate completion date of September 24, 2026. The New York Stem Cell Foundation Inc. has a history of working with various NIH agencies, including the National Institute on Drug Abuse, National Institute on Aging, and National Institute of Dental and Craniofacial Research, on federally funded research related to stem cell biology and its applications in conditions such as Alzheimer's disease, psychiatric disorders, and diabetes.
Quick answers
Who was awarded contract 75N92025P00392?
75N92025P00392 was awarded to New York Stem Cell Foundation Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 25, 2025.
How much is contract 75N92025P00392 worth?
The government has obligated $0 on 75N92025P00392.
Which agency awarded contract 75N92025P00392?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92025P00392, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92025P00392 competed?
The extent of competition for 75N92025P00392 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award